Target Prices Rise Across Healthcare, REITs

Analysts raised targets broadly on Friday, with upgrades spanning pharma, real estate, and financial services.

ABBV led the healthcare moves. The average analyst target climbed to $273.86. AbbVie carries a market cap above $434 billion. Short interest sits at just 1.3% of free float — bears are not pressing the stock.

Alexandria Real Estate Equities attracted a target hike to $52.36. The life-science REIT has been under pressure, with short interest at 5.2% of free float. The upgrade signal is notable given the stock's bearish positioning.

Diamondback Energy was the main downward revision. Analysts trimmed the average target slightly to $232.75. The oil producer faces headwinds from softer crude prices. Short interest is modest at 4.4% of free float.

Paramount Skydance saw the consensus target drop to $9.81. The media company carries the highest short interest in today's batch at 9.7% of free float. Analysts remain divided — seven buys versus three sells.

Amgen received a target lift to $378.31. The biotech stock has a mixed analyst split. Four buys face 13 sells, keeping sentiment cautious despite the price target bump.

This is not financial advice.